Low uptake of continuous subcutaneous insulin infusion therapy in people with type 1 diabetes in Ireland: a retrospective cross-sectional study

The uptake of continuous subcutaneous insulin infusion (CSII) therapy in those with type 1 diabetes varies internationally and is mainly determined by the national healthcare reimbursement systems. The aim of ...

Source: BMC Endocrine Disorders - June 23, 2020 Category: Endocrinology Authors: Katarzyna Anna Gajewska, Kathleen Bennett, Regien Biesma and Seamus Sreenan Tags: Research article Source Type: research